Shantam Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 4.00 M
as on 13-12-2024
- Paid Up Capital ₹ 3.50 M
as on 13-12-2024
- Company Age 29 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 4.95 Cr
as on 13-12-2024
- Satisfied Charges ₹ 4.01 Cr
as on 13-12-2024
- Revenue 33.01%
(FY 2022)
- Profit 33.59%
(FY 2022)
- Ebitda 16.70%
(FY 2022)
- Net Worth 10.17%
(FY 2022)
- Total Assets 20.93%
(FY 2022)
About Shantam Pharmaceuticals
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 4.00 M and a paid-up capital of Rs 3.50 M.
The company currently has active open charges totaling ₹4.95 Cr. The company has closed loans amounting to ₹4.01 Cr, as per Ministry of Corporate Affairs (MCA) records.
Shaleshkumar Bhalani and Bhaskar Bhalani serve as directors at the Company.
- CIN/LLPIN
U24230GJ1995PTC024121
- Company No.
024121
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Jan 1995
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Rajkot, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
What products or services does Shantam Pharmaceuticals Pvt Ltd offer?
Shantam Pharmaceuticals Pvt Ltd offers a wide range of products and services, including Nutraceuticals & Dietary Supplements, Dietary Supplements.
Who are the key members and board of directors at Shantam Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shaleshkumar Bhalani  | Director | 13-Nov-2014 | Current |
| Bhaskar Bhalani | Director | 15-Dec-2014 | Current |
Financial Performance of Shantam Pharmaceuticals.
Shantam Pharmaceuticals Pvt Ltd, for the financial year ended 2022, experienced significant growth in revenue, with a 33.01% increase. The company also saw a substantial improvement in profitability, with a 33.59% increase in profit. The company's net worth Soared by an impressive increase of 10.17%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Shantam Pharmaceuticals?
Unlock access to Shantam Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Axis Bank Limited Creation Date: 02 Aug 2022 | ₹4.15 Cr | Open |
Axis Bank Limited Creation Date: 22 Jun 2022 | ₹8.00 M | Open |
Others Creation Date: 28 Jan 2017 | ₹1.39 Cr | Satisfied |
How Many Employees Work at Shantam Pharmaceuticals?
Shantam Pharmaceuticals has a workforce of 11 employees as of Apr 06, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Shantam Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Shantam Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
